Member Info for Elsol

SP looks very oversold and a great opportunity for big re-rate/rebound once RNS comes re: storm damage repair; All downside risk is in here - its got to be!

Great read Matterhorn, I've always known Man Flu actually existed ever since my ex-wife used to call me the " sick-boy" jokingly when I came down with anything more than a tickle. And I was really sick very often, she just bounced back from flu etc and I was as sick as a dog ....just as an aside: if the SNG001 results show something approaching 90 to 100% reduction in risk of death in SPRINTER with no material side effects when the data is unlocked on 16th Dec is it then likely that headline will be announced quickly publically and communicated to the FDA and EMA? If its conclusive and a no brainer data readout then is there a prospect Santa could come before 25th or am I barking up the wrong tree???

They could be incinerated soonishhhhhh..... :-)

Perfect timing for their little pre Xmas feast eh?

The two "P's" certainly think there is a big value crystalisation event on the way soon don't you think??

CityTrader thanks for headlines a few days ago. have a gold star for correctly calling this one. I believed you at the time but its good to get the RNS today.

Is it about 12 more days to unlocking the clinical data? Not long to wait then......if its really good as we expect there must be some preliminary white smoke from the Sistene Chapel! There will be intense pre Christmas dialogue on commercialisation and manufacturing ramp up. There must be existing plans and companies identified for support subject to readout results.

Look on the bright side Japanone: At least you can buy c.5% more shares Monday if you get in quick based on the negative rumors today caused by a 'unbiased'/jealous Prof helped by someone selling some stock before announcing this headline.

In fact, serious 'Cytokine Release Syndrome' (CRS) only kicks in during the latter phase of severe covid disease and most of the entrants to the SPRINTER clinical trial were pre-intubation, in fact newcomers to hospital with mild to moderate breathlessness. So the Profs. comments wont effect the Phase III successful readout. SNG001 probably works over 80% of the lifecycle to death timeline that's my view. Good luck all. We should know by Jan 10th.

Irrespective of the observed new variant severity of symptoms, it just highlights how agile this little bugg*r is and the prospect of further radical change to its RNA code over the next 2 to 3 years. Its got a real ocean of human populations to feed on and mutate over 2022 to 24 so that's the big concern. If it can achieve 20 to 30 changes to its RNA sequence in a matter of months then watch out we need all the tools that science can throw at it. Vax, Therapies and masks. Obviously SNG too.

Come on Bruce cut Andy some slack, he may only have a few quid invested and the rest in build soc accounts...many do!

What the f has that got to do with ITX????? time waster

I think the upside of the range is squashed down a bit since I believe there will be some societal and government pressure building to do the right thing especially for poorer countries not take too much profit per dose. Could be wrong. However even with this pricing pressure I'm still thinking £15 to £20 per share is not unreasonable an expectation for a best in class secondary care focused treatment like SNG001.

My warning advice: STRONG HOLD
Why?
There is an unusually LARGE value gap between the Intrinsic/Economic/Mathematical modelled value of SNG supported by the strong science, safety data, mode of action, clinical evidence, probability of launch, perceived risk, massive unmet needs, SNG significant staff build up investment, "we know it works" etc etc.
AS COMPARED TO ITS CURRENT SMALL MARKET CAP.
At any one time there is only " One mid point value."
So, either the facts need to change radically (downwards= most of them) to equate to the current SP value OR the value in this stock will need to rise very significantly, even pre-SPRINTER. So beware everyone. Hold tight otherwise you could be kicking yourself very soon when the stars and importantly THE CURRENT FACTS embedding value all come into alignment as they will.

I think trading in out is getting much more risky now. Its so close to highly visible shareholder demand pull from a totally new pool of non scientific based investors. I'm staying in. You've got to be in it to win it! All it will take is more positive news and awareness awakening from anywhere not just SPRINTER readout.

And does this charting work when risk is being unwound so close to what could be a massive SP technology inflection point?

They may have stopped accumulating. Strategic minority holding built up to a portfolio level.

Dawn small keyboard, I keep ****smellung my worms

For our major cross transfection rainbow party that is!

It's temporary covid news and traders seeking day trade opps. I agree its frustrating. However, our major customers are going to increase their stock levels soon since they cannot afford supply chain delay for their end markets as has been experienced due to storm interruptions. Means ITX will be delivering v strong Q1 ;& Q2 this year compared to last.

Hi Doc83. Sorry if I'm being a bit thick, but aren't you alot better going all in tomorrow because you probably won't get a mediocre share price rise to buy into during a hypothetical subdued rise at that near future time point when P3 headline results are out!! You may feel a bit of a t×at missing out because once the cats out of the bag so to speak the world of private investors and big pharma and biotech will see SNG in full daylight and know they are onto an historically under appreciated and very under valued little winner in the Grand National.